Technology
Health
Biotechnology

Biofrontera

$17.25
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.91 (5.57%) Today
$0.00 (0.00%) As of 4:00 PM EDT after-hours

Why Robinhood?

You can buy or sell Biofrontera and other stocks, options, ETFs, and crypto commission-free!

About BFRA

Biofrontera AG operates as a biopharmaceutical company, which engages in the development, sale and distribution of dermatological drugs and medical cosmetics for the care, protection and treatment of the skin. Its products are used for the treatment of chronic, antihistamine refractory urticaria and migraine prophylaxis. Read More The company was founded by Hermann Lübbert in 1997 and is headquartered in Leverkusen, Germany.

Employees
157
Headquarters
Leverkusen, Nordrhein-Westfalen
Founded
1997
Market Cap
384.96M
Price-Earnings Ratio
Dividend Yield
Average Volume
3.61K
High Today
Low Today
Open Price
Volume
0.00
52 Week High
$18.32
52 Week Low
$11.04

Collections

Technology
Health
Biotechnology
Biopharmaceutical
Medical
Cosmetics
Pharmaceutical
Retail

BFRA News

BenzingaJun 24

Biofrontera's CFO On The Dermatology Biotech's Pipeline, Growth, Acquisitions And More

129
Seeking AlphaJun 21

Biofrontera board members back partial tender offer

48

BFRA Earnings

Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
Actual
Available Aug 30, Pre-Market

More BFRA News

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.